FR04C0021I2 - METHOD FOR ELIMINATING BILE SALTS IN A PATIENT AND ALKYLATED COMPOSITIONS FOR THIS PURPOSE - Google Patents
METHOD FOR ELIMINATING BILE SALTS IN A PATIENT AND ALKYLATED COMPOSITIONS FOR THIS PURPOSEInfo
- Publication number
- FR04C0021I2 FR04C0021I2 FR04C0021C FR04C0021C FR04C0021I2 FR 04C0021 I2 FR04C0021 I2 FR 04C0021I2 FR 04C0021 C FR04C0021 C FR 04C0021C FR 04C0021 C FR04C0021 C FR 04C0021C FR 04C0021 I2 FR04C0021 I2 FR 04C0021I2
- Authority
- FR
- France
- Prior art keywords
- patient
- bile salts
- alkylated
- eliminating
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F220/60—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/02—Alkylation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/44—Preparation of metal salts or ammonium salts
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
- C08L39/02—Homopolymers or copolymers of vinylamine
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25843194A | 1994-06-10 | 1994-06-10 | |
PCT/US1995/007181 WO1995034585A1 (en) | 1994-06-10 | 1995-06-05 | Process for removing bile salts from a patient and alkylated compositions therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
FR04C0021I1 FR04C0021I1 (en) | 2007-10-26 |
FR04C0021I2 true FR04C0021I2 (en) | 2008-05-16 |
Family
ID=22980525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR04C0021C Active FR04C0021I2 (en) | 1994-06-10 | 2004-09-08 | METHOD FOR ELIMINATING BILE SALTS IN A PATIENT AND ALKYLATED COMPOSITIONS FOR THIS PURPOSE |
Country Status (21)
Country | Link |
---|---|
US (12) | US5679717A (en) |
EP (2) | EP0909768A3 (en) |
JP (1) | JP3931217B2 (en) |
KR (1) | KR100271693B1 (en) |
CN (1) | CN1150217C (en) |
AT (1) | ATE184027T1 (en) |
AU (1) | AU698752C (en) |
CA (1) | CA2191478C (en) |
DE (3) | DE122004000034I1 (en) |
DK (1) | DK0764174T3 (en) |
ES (1) | ES2135743T3 (en) |
FR (1) | FR04C0021I2 (en) |
GR (1) | GR3031702T3 (en) |
IL (2) | IL114073A (en) |
LU (1) | LU91100I2 (en) |
MX (1) | MX9606171A (en) |
NL (1) | NL300159I2 (en) |
NZ (1) | NZ288076A (en) |
RU (1) | RU2160742C2 (en) |
TW (1) | TW474813B (en) |
WO (1) | WO1995034585A1 (en) |
Families Citing this family (130)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5487888A (en) | 1993-05-20 | 1996-01-30 | Geltex, Inc. | Iron-binding polymers for oral administration |
US5929184A (en) * | 1993-06-02 | 1999-07-27 | Geltex Pharmaceuticals, Inc. | Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants |
US6129910A (en) * | 1993-06-02 | 2000-10-10 | Geltex Pharmaceuticals, Inc. | Water-insoluble noncrosslinked bile acid sequestrants |
US5607669A (en) * | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
TW474813B (en) * | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
US6203785B1 (en) | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
US5925379A (en) * | 1997-03-27 | 1999-07-20 | Geltex Pharmaceuticals, Inc. | Interpenetrating polymer networks for sequestration of bile acids |
US6423754B1 (en) * | 1997-06-18 | 2002-07-23 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with polyallylamine polymers |
US5985938A (en) * | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US6083497A (en) * | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
US6566407B2 (en) | 1997-11-05 | 2003-05-20 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
US6264937B1 (en) | 1998-01-09 | 2001-07-24 | Geltex Pharmaceuticals, Inc. | Fat-binding polymers |
US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
US6299868B1 (en) | 1999-07-14 | 2001-10-09 | Geltex Pharmaceuticals, Inc. | Fat-binding polymers |
US7048917B1 (en) | 1998-01-09 | 2006-05-23 | Genzyme Corporation | Fat-binding polymers |
US6294163B1 (en) | 1998-10-02 | 2001-09-25 | Geltex Pharmaceuticals, Inc. | Polymers containing guanidinium groups as bile acid sequestrants |
JP4749649B2 (en) * | 1998-10-12 | 2011-08-17 | 中外製薬株式会社 | Phosphate-binding polymer |
TW568788B (en) * | 1998-10-12 | 2004-01-01 | Chugai Pharmaceutical Co Ltd | Polymer combining with phosphoric acid and preparation containing the same |
DE19850817A1 (en) | 1998-11-04 | 2000-05-11 | Basf Ag | Modified cationic polymers, processes for their manufacture and their use in papermaking |
US6271264B1 (en) * | 1998-12-01 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants |
EP1175451B1 (en) | 1999-04-16 | 2007-07-04 | Abbott Laboratories | Process for producing cross-linked polyallylamine hydrochloride |
US6190649B1 (en) | 1999-04-23 | 2001-02-20 | Geltex Pharmaceuticals, Inc. | Polyether-based bile acid sequestrants |
EP1196181A1 (en) * | 1999-07-14 | 2002-04-17 | Geltex Pharmaceuticals, Inc. | Fat-binding polymers, optionally combined with lipase inhibitors |
US6180754B1 (en) | 1999-09-03 | 2001-01-30 | The Dow Chemical Company | Process for producing cross-linked polyallylamine polymer |
US6362266B1 (en) | 1999-09-03 | 2002-03-26 | The Dow Chemical Company | Process for reducing cohesiveness of polyallylamine polymer gels during drying |
US20020054903A1 (en) * | 1999-10-19 | 2002-05-09 | Joseph Tyler | Direct compression polymer tablet core |
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
MXPA03000771A (en) * | 2000-07-28 | 2003-06-04 | Hoffmann La Roche | New pharmaceutical composition. |
CA2428800C (en) | 2000-11-20 | 2011-09-13 | Dow Global Technologies Inc. | In vivo use of fluid absorbent polymers |
US8263112B2 (en) * | 2000-11-20 | 2012-09-11 | Sorbent Therapeutics, Inc. | In vivo use of water absorbent polymers |
ES2349093T3 (en) | 2000-11-28 | 2010-12-27 | Mitsubishi Tanabe Pharma Corporation | EXCRETION ACCELERATOR FOR AN ACUMULATIVE CHLORINE COMPOUND. |
AT409630B (en) * | 2000-12-13 | 2002-09-25 | Dsm Fine Chem Austria Gmbh | ALKYLATION OF N-BZW. CROSSLINKED POLYMERS CONTAINING AMINO OR AMMONIUM GROUPS |
US6710162B2 (en) | 2001-02-16 | 2004-03-23 | Genzyme Corporation | Method of drying a material having a cohesive phase |
EP1923064B1 (en) | 2001-04-18 | 2017-06-28 | Genzyme Corporation | Use of amine polymer for lowering serum glucose |
WO2002085379A1 (en) * | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for improving vascular access in patients with vascular shunts |
AU2002252632B2 (en) * | 2001-04-18 | 2004-09-23 | Genzyme Corporation | Low salt forms of polyallylamine |
EP1379259A1 (en) * | 2001-04-18 | 2004-01-14 | Genzyme Corporation | Methods of treating syndrome x with aliphatic polyamines |
JP4499363B2 (en) * | 2001-04-18 | 2010-07-07 | ジェンザイム コーポレーション | Method for reducing serum glucose |
WO2002085380A1 (en) * | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for treating gout and reducing serum uric acid |
US7041280B2 (en) * | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
US7049345B2 (en) * | 2001-06-29 | 2006-05-23 | Genzyme Corporation | Fat-binding polymers |
US6600011B2 (en) | 2001-10-09 | 2003-07-29 | Genzyme Corporation | Process for purification and drying of polymer hydrogels |
AT414237B (en) * | 2002-09-03 | 2006-10-15 | Dsm Fine Chem Austria Gmbh | Preparation of haloalkyl-ammonium salt, useful as alkylating agent, comprises reacting trimethylamine with dihaloalkane compound in presence of ethyl acetate, cooling the reaction mixture, filtering and drying the reaction mixture |
AT411463B (en) | 2002-09-03 | 2004-01-26 | Dsm Fine Chem Austria Gmbh | High yield production of alkylated nitrogen containing crosslinked polymer gels, e.g. epichlorohydrin crosslinked poly allylamine hydrochloride, comprises washing with methanol, sodium chloride and water |
AU2003282867A1 (en) * | 2002-10-22 | 2004-05-13 | Genzyme Corporation | Amine polymers for promoting bone formation |
OA13174A (en) | 2003-05-30 | 2006-12-13 | Ranbaxy Lab Ltd | Substituted pyrrole derivatives and their use as HMG-Co inhibitors. |
US7459502B2 (en) * | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
US7335795B2 (en) * | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
US7767768B2 (en) * | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
US7385012B2 (en) * | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
US7608674B2 (en) * | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
US7449605B2 (en) * | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
JPWO2005092349A1 (en) | 2004-03-26 | 2008-02-07 | 田辺三菱製薬株式会社 | Insulin resistance improving agent |
US8282960B2 (en) * | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
US8192758B2 (en) * | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US7556799B2 (en) * | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
US7854924B2 (en) | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
KR101153035B1 (en) * | 2004-03-30 | 2012-06-11 | 리립사, 인크. | Ion binding compositions |
US7429394B2 (en) * | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
EP1778740A1 (en) * | 2004-08-12 | 2007-05-02 | VersaMatrix A/S | Beaded and cross-linked poly(aminoalkylene) matrix and uses thereof |
WO2006021218A1 (en) * | 2004-08-27 | 2006-03-02 | Versamatrix A/S | Polyether polymer matrix |
JP2008510860A (en) * | 2004-08-27 | 2008-04-10 | ヴァーサマトリックス・アクティーゼルスカブ | High load functional resin |
US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
JP4547620B2 (en) * | 2004-12-02 | 2010-09-22 | 日東紡績株式会社 | Method for producing crosslinked allylamine polymers |
MY144940A (en) * | 2005-01-25 | 2011-11-30 | Avantor Performance Mat Inc | Chromatographic media |
EP1869090A1 (en) * | 2005-03-16 | 2007-12-26 | Council Of Scientific And Industrial Research | An improved process for the preparation of crosslinked polyallylamine polymer. |
US8986669B2 (en) | 2005-09-02 | 2015-03-24 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
AR056499A1 (en) * | 2005-09-06 | 2007-10-10 | Serapis Farmaceuticals Ltd | COMPOUNDS |
DK1924246T3 (en) | 2005-09-15 | 2016-01-18 | Genzyme Corp | PORTION LETTER DEFINITION OF amine polymers |
BRPI0616604A2 (en) | 2005-09-30 | 2012-12-25 | Ilypsa Inc | Method for Removing and Composition for Selectively Removing Potassium Ion from a Mammal's Gastrointestinal Tract, Method for Selectively Removing Potassium Ion from an Environment, Pharmaceutical Composition, Core-Wrap Particle, and, Uses of a Core-Wrap Particle and a pharmaceutical composition |
WO2007038802A2 (en) * | 2005-09-30 | 2007-04-05 | Ilypsa, Inc. | Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
CA2627599A1 (en) | 2005-11-08 | 2007-05-18 | Ranbaxy Laboratories Limited | Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt |
EP2016114A2 (en) * | 2006-05-05 | 2009-01-21 | Genzyme Corporation | Amine condensation polymers as phosphate sequestrants |
ES2398477T3 (en) | 2006-06-16 | 2013-03-19 | Mitsubishi Tanabe Pharma Corporation | Agent for the prevention and / or treatment of glomerulopathy |
FR2902799B1 (en) | 2006-06-27 | 2012-10-26 | Millipore Corp | METHOD AND UNIT FOR PREPARING A SAMPLE FOR THE MICROBIOLOGICAL ANALYSIS OF A LIQUID |
EP2041261A4 (en) * | 2006-07-13 | 2012-07-04 | Ass For Public Health Services | Inoculation loop assembly |
EP2049014A2 (en) * | 2006-07-18 | 2009-04-22 | Genzyme Corporation | Amine dendrimers |
EP2066293A2 (en) | 2006-09-29 | 2009-06-10 | Genzyme Corporation | Amide dendrimer compositions |
US8163799B2 (en) | 2006-12-14 | 2012-04-24 | Genzyme Corporation | Amido-amine polymer compositions |
US8163886B2 (en) | 2006-12-21 | 2012-04-24 | Emd Millipore Corporation | Purification of proteins |
US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
WO2008103368A1 (en) * | 2007-02-23 | 2008-08-28 | Genzyme Corporation | Amine polymer compositions |
WO2008109095A1 (en) * | 2007-03-08 | 2008-09-12 | Genzyme Corporation | Sulfone polymer compositions |
US20100166696A1 (en) * | 2007-04-27 | 2010-07-01 | Dhal Pradeep K | Amido-amine dendrimer compositions |
EP2016947A1 (en) | 2007-07-17 | 2009-01-21 | Chemo Ibérica, S.A. | Novel one step process for preparing cross-linked poly(allylamine) polymers |
JP2011506449A (en) * | 2007-12-14 | 2011-03-03 | ジェンザイム コーポレーション | Coating pharmaceutical composition |
PA8807201A1 (en) * | 2007-12-14 | 2009-07-23 | Genzyme Corp | PHARMACEUTICAL COMPOSITIONS |
US8999702B2 (en) | 2008-06-11 | 2015-04-07 | Emd Millipore Corporation | Stirred tank bioreactor |
WO2009154747A1 (en) * | 2008-06-20 | 2009-12-23 | Genzyme Corporation | Pharmaceutical compositions |
DE102008030046A1 (en) | 2008-06-25 | 2009-12-31 | Ratiopharm Gmbh | Preparation of tablets comprising polyallylamine polymer, useful for treating e.g. hyperphosphatemia, comprises mixing polyallylamine polymer and additives, compacting to slug, granulating the slug and compressing the granules into tablets |
US20100104527A1 (en) * | 2008-08-22 | 2010-04-29 | Relypsa, Inc. | Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties |
KR102178208B1 (en) * | 2008-08-22 | 2020-11-12 | 리립사, 인크. | Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia |
WO2010022380A2 (en) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Linear polyol stabilized polyfluoroacrylate compositions |
CA2735962A1 (en) * | 2008-09-02 | 2010-04-15 | Usv Limited | Crosslinked polymers |
US20120009242A1 (en) * | 2008-11-03 | 2012-01-12 | University Of Maryland, College Park | Blood coagulation inducing polymer hydrogel |
US8404784B2 (en) * | 2008-12-03 | 2013-03-26 | Navinta Llc | Manufacturing process of making polymeric amine salts |
CN102257122B (en) | 2008-12-16 | 2015-07-29 | Emd密理博公司 | Stirred tank reactor and method |
US8673272B2 (en) * | 2009-07-27 | 2014-03-18 | Isp Investments Inc. | Ultraviolet-absorbing compounds |
GB0915449D0 (en) * | 2009-09-04 | 2009-10-07 | Univ Robert Gordon | Composition |
BR112012021444A2 (en) | 2010-02-24 | 2016-05-31 | Relypsa Inc | cross-linked amine polymer, pharmaceutical composition, method of lowering serum ldl cholesterol in an individual, methods for treating disease, removing bile salts from an individual, and for improving glycemic control in an individual, and process for preparing the polymer of amines. |
CN102906159B (en) * | 2010-02-24 | 2017-09-26 | 瑞立普萨公司 | Amine polymer as bile acid sequestrant |
WO2011146394A1 (en) * | 2010-05-17 | 2011-11-24 | Millipore Corporation | Stimulus responsive polymers for the purification of biomolecules |
TR201005327A2 (en) | 2010-06-30 | 2012-01-23 | Bi̇lgi̇ç Mahmut | Synergistic pharmaceutical formulations. |
WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
BR112013010157B1 (en) | 2010-11-08 | 2020-02-04 | Albireo Ab | ibat inhibitors, their uses, and pharmaceutical composition and combinations |
SG190433A1 (en) | 2010-11-08 | 2013-06-28 | Albireo Ab | A pharmaceutical combination comprising an ibat inhibitor and a bile acid binder |
US20140243281A1 (en) | 2011-10-28 | 2014-08-28 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
US20130123433A1 (en) | 2011-11-14 | 2013-05-16 | Formosa Laboratories, Inc. | Method for preparing poly(allylamine) hydrochloride and derivatives therefrom |
US10813946B2 (en) | 2012-10-08 | 2020-10-27 | Vifor (International) Ltd. | Potassium binding polymers for treating hypertension and hyperkalemia |
ES2471340B1 (en) | 2012-12-21 | 2015-08-17 | Laboratorios Rubió, S.A. | Oral pharmaceutical composition for high dosage drugs |
EP2970196B1 (en) * | 2013-03-15 | 2020-11-25 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
CN103446179B (en) * | 2013-05-14 | 2017-03-15 | 厦门绿洲安源投资管理有限公司 | The application of the tree-shaped crosslinking polycation gel of the poly- fullerene of parents of binding chelating agent as phosphate, aliphatic acid and bile acid |
HUE051198T2 (en) | 2013-06-05 | 2021-03-01 | Tricida Inc | Proton-binding polymers for oral administration |
US9475891B2 (en) | 2013-09-19 | 2016-10-25 | Navinta, Llc | Process for the preparation of colesevelam hydrochloride |
EP2875807B1 (en) | 2013-11-20 | 2021-03-24 | Sanovel Ilac Sanayi ve Ticaret A.S. | Tablet formulation of colesevelam |
ITMI20132132A1 (en) | 2013-12-19 | 2015-06-20 | Chemi Spa | PROCESS FOR THE PREPARATION OF COLESEVELAM |
JP2017517550A (en) | 2014-06-13 | 2017-06-29 | ユナイテッド セラピューティクス コーポレイション | Treprostinil preparation |
ES2857177T3 (en) | 2014-12-10 | 2021-09-28 | Tricida Inc | Proton-binding polymers for oral administration |
US20180015119A1 (en) | 2015-02-23 | 2018-01-18 | Amneal Pharmaceuticals Company Gmbh | Process for granulating sevelamer carbonate |
US20170114157A1 (en) | 2015-10-21 | 2017-04-27 | Saudi Arabian Oil Company | Cationic polymers and porous materials |
MA54925A (en) | 2016-05-06 | 2021-12-22 | Tricida Inc | COMPOSITIONS FOR THE TREATMENT OF ACID-BASED DISORDERS |
CN106008813B (en) * | 2016-06-15 | 2017-11-14 | 新发药业有限公司 | The method that polymerisation in solution prepares colesevelam hydrocholoride |
US10563042B2 (en) | 2016-12-14 | 2020-02-18 | Ecolab Usa Inc. | Quaternary cationic polymers |
CN107232191B (en) * | 2017-06-22 | 2021-05-18 | 华中师范大学 | Perfluorobutyl modified polyethyleneimine macromolecular fluorine-containing surfactant, preparation thereof and application thereof in pesticide slow release |
AU2018360867A1 (en) | 2017-11-03 | 2020-04-30 | Tricida, Inc. | Compositions for and method of treating acid-base disorders |
WO2019241056A1 (en) | 2018-06-12 | 2019-12-19 | Ecolab Usa Inc. | Quaternary cationic surfactants and polymers for use as release and coating modifying agents in creping and tissue papers |
CN112047854B (en) * | 2020-10-20 | 2021-07-02 | 中国科学院长春应用化学研究所 | Preparation method of N-vinyl alkyl amide |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE580490A (en) * | 1958-07-15 | 1960-01-08 | Merck & Co Inc | Compositions and methods for lowering the cholesterol content of the blood |
US3383281A (en) * | 1961-09-22 | 1968-05-14 | Merck & Co Inc | Method for binding bile acids in vivo |
US3308020A (en) * | 1961-09-22 | 1967-03-07 | Merck & Co Inc | Compositions and method for binding bile acids in vivo including hypocholesteremics |
US3288770A (en) * | 1962-12-14 | 1966-11-29 | Peninsular Chem Res Inc | Water soluble quaternary ammonium polymers |
BE756035A (en) * | 1969-09-12 | 1971-03-11 | Inveresk Res Int | POLYMERS BRIDGES |
US3803237A (en) * | 1969-11-03 | 1974-04-09 | Upjohn Co | Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds |
NL7017227A (en) * | 1969-12-27 | 1971-06-29 | ||
US3692895A (en) * | 1970-09-08 | 1972-09-19 | Norman A Nelson | Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria |
US3980770A (en) * | 1971-06-04 | 1976-09-14 | Pharmacia Aktiebolag | Polymerization products containing amino groups useful in serum cholesterol level control |
AR206390A1 (en) | 1973-02-05 | 1976-07-23 | Rohm & Haas | A MATRIX OF RETICULATED POLYMER RESIN AND PROCEDURE FOR ITS PREPARATION |
US4217429A (en) * | 1973-06-11 | 1980-08-12 | Merck & Co., Inc. | Poly-[(methylimino)trimethylene] |
US4205064A (en) * | 1973-06-11 | 1980-05-27 | Merck & Co., Inc. | Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides] |
US4027009A (en) * | 1973-06-11 | 1977-05-31 | Merck & Co., Inc. | Compositions and methods for depressing blood serum cholesterol |
CS187563B1 (en) * | 1974-02-08 | 1979-02-28 | Petr Strop | Method of preparation of the hydrophilic homogeneous or macroporous annexes |
CS173201B1 (en) * | 1974-02-13 | 1977-02-28 | ||
US4016209A (en) * | 1975-04-23 | 1977-04-05 | Merck & Co., Inc. | 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof |
US4101478A (en) * | 1976-04-12 | 1978-07-18 | Kostjuchenko Vladimir Mitrofan | Synthetic rubber mix |
US4071478A (en) * | 1976-06-07 | 1978-01-31 | Merck & Co., Inc. | Controlled partially cross-linked 3,3-ionenes |
FI67483C (en) * | 1977-02-17 | 1985-04-10 | Merck & Co Inc | PROCEDURE FOR THE FRAMEWORK OF ETHCYCLE ADMINISTRATION OF PHARMACOLOGICAL PRODUCT AGAINST GALLSYRAK COMPLEX BILDANDE ADSORBATE PREPARATION |
US4298715A (en) * | 1978-03-01 | 1981-11-03 | Monsanto Company | Polyamine/epihalohydrin reaction products |
JPS5566513A (en) * | 1978-11-14 | 1980-05-20 | Ono Pharmaceut Co Ltd | Drug for arteriosclerosis comprising high polymer compound as active constituent |
IT1106718B (en) * | 1978-12-21 | 1985-11-18 | Alfa Farmaceutici Spa | PHARMACOLOGICALLY ACTIVE SALONIZED ANIONIC RESIN BASED COMPOSITIONS |
EP0098884B1 (en) * | 1982-01-18 | 1986-07-23 | Mitsubishi Petrochemical Co., Ltd. | Cholesterol lowering drug |
JPS6090243A (en) * | 1983-10-25 | 1985-05-21 | Nitto Boseki Co Ltd | Small spherical crosslinked monoallylamine polymer and its preparation |
JPS60106803A (en) * | 1983-11-14 | 1985-06-12 | Nitto Boseki Co Ltd | Production of allylurea polymer |
EP0142962A3 (en) * | 1983-11-14 | 1986-01-15 | Nitto Boseki Co., Ltd. | Process for producing poly (allylamine) derivatives |
US4540760A (en) * | 1984-01-11 | 1985-09-10 | Nitto Boseki Co. Ltd. | Process for producing polymers of monoallylamine |
DE3572985D1 (en) * | 1984-05-11 | 1989-10-19 | Bristol Myers Co | Novel bile sequestrant resin and uses |
US4759923A (en) * | 1987-06-25 | 1988-07-26 | Hercules Incorporated | Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives |
US5300566A (en) * | 1988-04-15 | 1994-04-05 | Air Products And Chemicals, Inc. | Method for preparing poly(vinyl alcohol)-co-poly(vinylamine) via a two-phase process |
DE3901527A1 (en) | 1989-01-20 | 1990-07-26 | Hoechst Ag | ALKYLATED POLYETHYLENE IMIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS |
US5236701A (en) * | 1989-07-19 | 1993-08-17 | Lowchol Scientific Inc. | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
GB8928278D0 (en) * | 1989-12-14 | 1990-02-21 | Smith Kline French Lab | Compounds |
GB9011332D0 (en) * | 1990-05-21 | 1990-07-11 | Smith Kline French Lab | Compounds |
IE914179A1 (en) * | 1990-12-07 | 1992-06-17 | Ici Plc | Nitrogen derivatives |
US5055197A (en) * | 1991-04-05 | 1991-10-08 | Rohm And Haas Company | Process for removing residual monomers and oligemers from amine-containing polymers |
US5142019A (en) * | 1991-10-03 | 1992-08-25 | Ppg Industries, Inc. | Oligomers formed from reaction of acrylamidoglycolate alkyl ethers with β-hydroxyalkylamines |
ATE159262T1 (en) * | 1992-07-22 | 1997-11-15 | Hoechst Ag | POLYVINYLAMINE DERIVATIVES HAVING HYDROPHILIC CENTERS, METHOD FOR THE PRODUCTION THEREOF AND THE USE OF THE COMPOUNDS AS MEDICINAL PRODUCTS, ACTIVE CARRIERS AND FOOD ADDITIVES |
DK0580079T3 (en) * | 1992-07-22 | 1997-06-30 | Hoechst Ag | Cross-linked, nitrogen-containing vinyl copolymers, processes for their preparation and use of these compounds |
JP3412842B2 (en) * | 1992-07-28 | 2003-06-03 | ミヨシ油脂株式会社 | Metal collecting agent and method for producing the same |
RU95107405A (en) * | 1992-08-20 | 1997-02-10 | Е. И. Дюпон Де Немур энд Компани (US) | Cross-linked polymer ammonium salt, pharmaceutical composition, method for decreasing of cholesterol content in blood plasma, method for promotion of excretion of cholic acids |
US5451397A (en) * | 1992-12-21 | 1995-09-19 | Rohm And Haas Company | Bile acid sequestrant |
US5607669A (en) | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
EP0706399A4 (en) * | 1993-06-02 | 1998-08-12 | Geltex Pharma Inc | Compositions and process for removing bile salts |
US5624963A (en) | 1993-06-02 | 1997-04-29 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5703188A (en) | 1993-06-02 | 1997-12-30 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5667775A (en) * | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US5414068A (en) * | 1994-01-24 | 1995-05-09 | Rohm And Haas Company | Crosslinked anion exchange particles and method for producing the particles |
TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
-
1995
- 1995-05-22 TW TW084105201A patent/TW474813B/en not_active IP Right Cessation
- 1995-06-05 DE DE200412000034 patent/DE122004000034I1/en active Pending
- 1995-06-05 RU RU96124807/04A patent/RU2160742C2/en active
- 1995-06-05 DE DE1995611861 patent/DE122004000034I2/en active Active
- 1995-06-05 AU AU26990/95A patent/AU698752C/en not_active Expired
- 1995-06-05 NZ NZ288076A patent/NZ288076A/en not_active IP Right Cessation
- 1995-06-05 ES ES95922232T patent/ES2135743T3/en not_active Expired - Lifetime
- 1995-06-05 DE DE69511861T patent/DE69511861T2/en not_active Expired - Lifetime
- 1995-06-05 WO PCT/US1995/007181 patent/WO1995034585A1/en active IP Right Grant
- 1995-06-05 US US08/460,980 patent/US5679717A/en not_active Expired - Lifetime
- 1995-06-05 DK DK95922232T patent/DK0764174T3/en active
- 1995-06-05 US US08/461,298 patent/US5693675A/en not_active Expired - Lifetime
- 1995-06-05 JP JP50230696A patent/JP3931217B2/en not_active Expired - Lifetime
- 1995-06-05 KR KR1019960707054A patent/KR100271693B1/en not_active IP Right Cessation
- 1995-06-05 CA CA002191478A patent/CA2191478C/en not_active Expired - Lifetime
- 1995-06-05 AT AT95922232T patent/ATE184027T1/en active
- 1995-06-05 CN CNB951935216A patent/CN1150217C/en not_active Expired - Lifetime
- 1995-06-05 EP EP98203744A patent/EP0909768A3/en not_active Withdrawn
- 1995-06-05 EP EP95922232A patent/EP0764174B1/en not_active Expired - Lifetime
- 1995-06-08 IL IL11407395A patent/IL114073A/en not_active IP Right Cessation
-
1996
- 1996-12-06 MX MX9606171A patent/MX9606171A/en unknown
-
1998
- 1998-08-05 US US09/129,286 patent/US5917007A/en not_active Expired - Lifetime
-
1999
- 1999-04-08 US US09/288,357 patent/US5981693A/en not_active Expired - Lifetime
- 1999-09-02 US US09/388,876 patent/US6066678A/en not_active Expired - Lifetime
- 1999-11-03 GR GR990402794T patent/GR3031702T3/en unknown
-
2000
- 2000-03-22 US US09/532,984 patent/US6225355B1/en not_active Expired - Lifetime
-
2001
- 2001-03-09 US US09/803,647 patent/US6433026B2/en not_active Expired - Lifetime
- 2001-04-03 IL IL14241901A patent/IL142419A0/en unknown
-
2002
- 2002-01-30 US US10/060,556 patent/US20020095002A1/en not_active Abandoned
- 2002-10-03 US US10/264,350 patent/US6784254B2/en not_active Expired - Lifetime
-
2004
- 2004-07-07 US US10/886,016 patent/US7101960B2/en not_active Expired - Fee Related
- 2004-09-06 NL NL300159C patent/NL300159I2/en unknown
- 2004-09-08 LU LU91100C patent/LU91100I2/en unknown
- 2004-09-08 FR FR04C0021C patent/FR04C0021I2/en active Active
-
2006
- 2006-07-24 US US11/491,788 patent/US7399821B2/en not_active Expired - Lifetime
-
2008
- 2008-07-11 US US12/218,227 patent/US20090155201A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR04C0021I2 (en) | METHOD FOR ELIMINATING BILE SALTS IN A PATIENT AND ALKYLATED COMPOSITIONS FOR THIS PURPOSE | |
EP0944552A4 (en) | Method for removing toxic substances in water | |
GB9521826D0 (en) | Method and composition for clarifying waste water | |
FR2726754B1 (en) | DEVICE AND METHOD FOR EXAMINING VISUAL FUNCTIONS | |
ZA959552B (en) | Method for use in casting technology | |
EE9700114A (en) | Method and apparatus for waste water treatment | |
FR2723835B1 (en) | METHOD FOR CREATING ANATOMICAL MODE DISPLAYS | |
EP0758234A4 (en) | Method and composition for treating renal disease and failure | |
HU9501346D0 (en) | Parts for supporting drinking water and method for treatment thereof | |
GB2305371B (en) | Wear strip assembly for use in a waste water treatment facility | |
GB9708732D0 (en) | Method for transferring waste | |
FR2757401B1 (en) | METHOD FOR TRIGGERING OVULATION IN A MAMMAL | |
IL110020A (en) | Apparatus and method for purifying waste water | |
HUP9601049A2 (en) | Waste water treatment method | |
FR2722577B1 (en) | METHOD AND DEVICE FOR DETERMINATION BY INTRODUCTION IN A REAGENT IN THE FORM OF PEBTS | |
ZA912113B (en) | Method and composition for water treatment | |
GB9501400D0 (en) | Method for treating water | |
FR2770094B1 (en) | METHOD AND DEVICE FOR CREATING ARTIFICIAL SHEETS AND FLOWERS | |
AU3516993A (en) | Method and device for treating water in a surface condenser | |
GB2285534B (en) | Method for treating radioactive waste solution | |
AU3177399A (en) | A method and a device for automatic circulation in waste water tank | |
AU2822695A (en) | Method and apparatus for waste water treatment | |
GB9410262D0 (en) | A method for treating waste water | |
GB2297500B (en) | Waste water treatment plant and method for use therein | |
GB9608334D0 (en) | Method for rapidly solidying water in a container |